Respiratory / Pulmonary disorders

The overall worldwide prevalence of Asthma ranges from 1% to 18%, affecting 300 million people worldwide.  Asthma is the most common chronic disease among children and affects millions of adults. There is a twofold increase in the prevalence of asthma in Jordan in the last 10 years.

Monitoring a respiratory study requires knowledge of the specific disease and associated guidelines. Our team are experienced with Specialized tests such as spirometry, body plethysmography, lung diffusion capacity that are required to manage the disease. 

Triumpharma experience in Respiratory/Pulmonary disorders Clinical trials

We have over 10 years of experience in conducting Respiratory/Pulmonary disorders clinical trials, with emphasis on key indications: Allergies, Asthma, COPD, and Asthmatic Bronchitis.